Literature DB >> 6109941

Association of isoapolipoprotein-E3 deficiency with heterozygous familial hypercholesterolaemia: implications for lipoprotein physiology.

W R Hazzard, N Miller, J J Albers, G R Warnick, P Baron, B Lewis.   

Abstract

A prepubertal girl with both homozygous isoapolipoprotein-E3 deficiency (the genetic defect underlying type-III hyperlipoproteinaemia) and heterozygous familial hypercholesterolaemia (familial type-IIa hyperlipoproteinaemia) presented with severe hypercholesterolaemia and antecubital and popliteal planar xanthomas. She responded dramatically to clofibrate. Her mother was normolipidaemic and heterozygous for apo-E3-deficiency. Her father, an obligate apo-E3-deficient heterozygote, and his similarly affected brother died prematurely with severe hypercholesterolaemia which had been refractory to clofibrate. Her paternal grandfather, who had the same combination of disorders as the proband, also responded to clofibrate, whereas her grandmother was normolipidaemic. Hence homozygous apo-E3 deficiency may present during childhood as severe hypercholesterolaemia when combined with familial hypercholesterolaemia, suggesting that the low-density-lipoprotein receptor may represent one mechanism whereby apo-E3-deficient remnants of very-low-density lipoproteins and chylomicrons are cleared from the plasma compartment. The removal of such apo-E3-deficient remnants is especially facilitated by clofibrate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6109941     DOI: 10.1016/s0140-6736(81)91911-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Plasma and lipoprotein lipid responses to four hypolipid drugs.

Authors:  W R Hazzard; P W Wahl; C Gagne; D Applebaum-Bowden; G R Warnick; J J Albers
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

Review 2.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

3.  Primary systemic amyloidosis presenting as extreme hyperlipidaemia with tendon xanthomas.

Authors:  Y Levy; P J Magill; N E Miller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

4.  DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia.

Authors:  M Vella; A Kessling; N Jowett; A Rees; J Stocks; S Wallis; D Galton
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.

Authors:  G Lindahl; F Mailly; S Humphries; M Seed
Journal:  Clin Investig       Date:  1994-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.